28.07.2016 14:20:46

Meridian Bioscience Inc. Profit Falls 4% In Q3

(RTTNews) - Meridian Bioscience Inc. (VIVO) announced earnings for third quarter that decreased from last year.

The company said its profit dropped to $8.75 million, or $0.21 per share. This was down from $9.10 million, or $0.22 per share, in last year's third quarter.

Analysts had expected the company to earn $0.22 per share, according figures compiled by Thomson Reuters. Analysts' estimates typically exclude special items.

The company said revenue for the quarter rose 5.1% to $50.66 million. This was up from $48.20 million last year.

Meridian Bioscience Inc. earnings at a glance:

-Earnings (Q3): $8.75 Mln. vs. $9.10 Mln. last year. -Earnings Decline (Y-o-Y): -3.8% -EPS (Q3): $0.21 vs. $0.22 last year. -EPS Decline (Y-o-Y): -4.5% -Analysts Estimate: $0.22 -Revenue (Q3): $50.66 Mln vs. $48.20 Mln last year. -Revenue Change (Y-o-Y): 5.1%

Nachrichten zu Meridian Bioscience Inc.mehr Nachrichten

Keine Nachrichten verfügbar.

Analysen zu Meridian Bioscience Inc.mehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!